Cor Therapeutics
South San Francisco, United States · Founded 1988 · $15.9M raised
- Headquarters
- South San Francisco, California
- Employees
- 51–200
- Founded
- 1988
- Business Model
- B2B
- Total Funding
- $15.9M
- Last Round
- $15.9M Venture Round
- Rounds
- 1
About
Biopharmaceutical company developing cardiovascular and oncological treatments including anti-thrombotic agents.
Summary
Cor Therapeutics is a Biotech company based in South San Francisco, United States, founded in 1988. It has raised $15.9M in total across 1 round. Investors include Sutter Hill, Glynn Capital and InterWest Partners.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Unknown
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.